We are delighted to present the new CFO of Reponex Thomas Kaas Selsø who will join the company on the 1st of March 2022.
We are delighted to present the new CFO of Reponex Thomas Kaas Selsø who will join the company on the 1st of March 2022.
Pharma Equity Group A/S
Slotsmarken 18, 2.th.
DK-2970 Hørsholm
Denmark
CVR 26791413
For general enquiries contact us at info@pharmaequitygroup.com
For Investor related enquiries contact us at investor@
For any drug quality issues, complaints or adverse events,
contact us at quality@reponex.dk
All rights reserved, 2024